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ABSTRACT 
 
Plasmablastic Lymphoma (PBL) is a hematolymphoid malignant disease that has a predilection for 
the oral cavity and jaw. The aim of this paper is report a total resolution of oral manifestation of 
PBL without any oncological treatment; this process is extremely rare and we discuss the 
mechanism which can occur. We present a case of PBL in left maxilla and oral mucosa in a 
woman HIV-positive patient. After an incisional biopsy an unusual outcome of spontaneous 
regression of the disease occurred, we reported the diagnostic process, the management and the 
Case Study 
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follow up of case. We revised the similar cases reported in the literature and we will discuss the 
hypotheses how the phenomenon can occur. Although the PBLs are aggressive lesions, with 
questionable prognosis, the spontaneous regression can occur and the patient should be 
monitored for the risk of metastases and possible recurrence of the disease. 
 
 
Keywords: Acquired immunodeficiency syndrome; jaw cancer; maxilla; plasmablastic lymphoma; 
spontaneous neoplasm regression. 
 
ABBREVIATIONS 
 
EBV : Epstein Barr Virus 
HAART : Highly Active Antiretroviral Therapy 
HHV8 : Human Herpes Virus 8 
HIV : Human Immunodeficiency Virus 
PBL : Plasmablastic Lymphoma 
PET : Positron Emission Tomography 
SR : Spontaneous Regression 
 
1. INTRODUCTION  
 
Some neoplasias are classified as Acquired 
Immunodeficiency Syndrome related cancers, 
especially Kaposi's sarcoma, high-grade B-cell 
non-Hodgkin's lymphoma and invasive cervical 
cancer [1]. Plasmablastic Lymphoma (PBL) is an 
aggressive form of diffuse large B-cell 
lymphoma, composed of large cells with 
morphology of immunoblasts and a plasma cell. 
History of immunodeficiency especially caused 
by HIV infection is common in patients with PBL. 
[2]. Some cases of this disease occurs at 
extranodal sites, especially in the oral cavity [3]. 
 
Even though prognosis is poor, a complete 
remission of disease without treatment can 
occur. This finding was reported initially in HIV+ 
patients that start the use of highly active 
antiretroviral therapy (HAART) [4,5,6] or yet 
which interrupted this therapy [7]. This 
phenomena has been seen in PBL in HIV+ 
patients with undetectable viral range and with 
immune system stable after the performance of 
an incisional biopsy [8,9].
 
Besides have been 
reports of spontaneous regression (SR) an HIV 
negative patient in absence of anti-neoplastic 
treatment [10,11]. The literature review reported 
eight cases of PBL SR without anti-neoplastic 
treatment (Table 1), we herein describe more 
one case of intraoral PBL that spontaneously 
regressed in the absence of any anti-neoplastic 
treatment. 
 
2. PRESENTATION OF CASE 
 
A 66-years-old woman was referred to our Oral 
Pathology Department showing a nodular lesion 
involving the maxillary region associated with 
painful symptoms with a history of approximately 
30 days. The patient’s medical history revealed 
HIV infection, hypertension and 
hypoparathyroidism, treated with HAART - 
abacavir/ lamivudine/ efavirenz, 
hydrochlorothiazide, amlodipine, enalapril, 
levothyroxine, calcium carbonate. Serological 
investigation presented undetectable viral load 
for HIV, 6 months ago, CD4 T-lymphocytes=480 
cel/μL (29-5827 cel/μL) and CD8 T-
lymphocytes=2950 cel/μL (22-4076 cel/μL). 
Additional clinical or laboratory analyses were 
unremarkable. The present study was conducted 
in accordance with the ethical guidelines set forth 
in the Declaration of Helsinki.   
 
Intraoral inspection showed an exophytic 
erythematous nodule with ulcerated areas on the 
maxillary left ridge, measuring approximately 3x4 
cm. On palpation the lesion had a fibrous 
consistency and the superior left first molar 
presented increased mobility (Fig. 1A). The 
panoramic radiograph revealed bone resorption 
in the left side of maxilla probably due to 
periodontal disease in the superior left first molar 
(Fig. 1B).  During the clinical evaluation no 
lymphadenopathy was detected. On the basis of 
these findings the clinical diagnoses were: 
malignant neoplasia or deep fungal infection. An 
incisional biopsy was performed. During the 
surgical procedure, the tissue was bleeding and 
friable. 
 
The specimen was submitted to histopathological 
analysis, which revealed a diffuse proliferation of 
large, round to oval cells, with typical 
plasmablastic features (i.e., immunoblastic 
morphology with abundant basophilic cytoplasm, 
occasional paranuclear hofs and prominent 
central nucleolus). Frequent apoptotic bodies 
and mitotic figures were seen (Fig. 2). 
Immunohistochemistry identified expression of 
CD138, CD38 and MUM1 by the neoplastic cells. 
No staining was seen with CD20, TDT, PAX-5, 
HHV8 and EMA (Table 2). Proliferative index 
accessed by Ki-67 reached more than 95% of 
the tumor cells. With these histopathologic and 
immunophenotypical findings the diagnosis of a 
plasmablastic lymphoma was established. The 
patient was referred to an oncologic center for 
appropriate treatment. 
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Table 1. Spontaneous regression of PBL cases without anti-neoplastic therapy 
Author 
year 
NASTA 
2002 
LESTER 
2004 
GILABERTE 
2005 
ARMSTRONG 
2007 
GARCÍA-NOBLEJAS 
2013 
CORTI 
2011 
IGAWA 
2015 
WAGNER 
2016 
Present 
case 
Gender Male Male Male Male Female Female Male Female Female 
Age 44 50 44 35 78 55 80 33 66 
Site Mediastinum Palate Arm Maxilla Buccal Mucosa Oral Maxilla Mandible Maxilla 
HIV + + + + - + - + + 
EBV - + + + + - + NI - 
HHV8 + NI + NI NI + NI NI - 
HAART 
before PBL 
Yes Yes Yes Yes No No No Yes, but  the 
therapy was 
interrupted 
Yes 
Therapy HAART HAART HAART HAART Decrease of 
Methotrexate 
HAART None HAART HAART 
Recurrence Yes Yes Yes No No No No No No 
NI- Not informed
Fig. 1. A) Clinical appearance of the PBL in the first exam 
proliferation adjacent to superior molar. B) Radiograph exam of the jaws, slight bone 
resorption associated a tooth
 
Fig. 2. A) Photomicrography shows the epithelial surface; 
was observed an intense hematolymphoid proliferation (H/E, 100x). B) The plasmablastic cells 
show vesicular nuclei, prominent nucleoli, and amphophilic cytoplasm (H/E, 400x). C) The 
main immunohistochemistry labeling for
 
Table 2. Immunohistochemistry panel of the lesion
Antibody 
CD 138 (MI15) 
CD38 (SPC32) 
MUM1 (MUM1P) 
CD79 (HM57) 
CD 20 (L26) 
PAX-5 (1EW) 
CD 3 (2GV6) 
CD 2 (11F11) 
ALK (ALK1) 
HHV8 (13B10) 
EMA(E29) 
TDT(Polyclonal) 
EBV (CSL/CS2/CS3/CS4) 
KI 67 (30-9) 
 
During the hospital admission, a fine
biopsy was performed by a general oncologist 
and the diagnosis of PBL was confirmed. The 
patient was then referred to a hematolymphoid 
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– exophytic erythematous 
 
 
in the connective tissue underlying 
 the final diagnoses was CD-138 membranous 
immunostaining (200x) 
 
 
Result Localization 
+ Membran Neoplastic B cells
+ Neoplastic B cells 
+ Nucleus Neoplastic B cells
- Tumor cell 
- Tumor cell 
- Tumor cell 
- Tumor cell 
- Tumor cell 
- Tumor cell 
- Tumor cell 
- Tumor cell 
-  Tumor cell 
- Tumor cell 
>95% Tumor cell 
-needle oncologist for specific treatment. While waiting 
for the consultation, the patient informed that she 
applied olive oil and Malva sylvestris
lesion four times/day every day. Surprisingly, at 
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 tea on the 
the moment of specialized oncologist 
appointment (one month later) the lesion 
disappeared clinically; in face of this finding, no 
oncologic therapy was performed at the time, 
only Positron Emission Tomography (PET) Scan 
was requested and it did not show any evidence 
of metastasis. 
 
During follow-up period, the patient underwent 
upper left first molar extraction with uneventful 
healing (Fig. 3). Fig. 4 shows the correlation 
between serological examination, the clinical 
lesion (appearance and regression) and the 
HAART therapy of the patient. The patient 
showed no recurrence of the oral lesion for 12 
months. However, in medical follow
PET-Scan, it was diagnosed tumor bone 
metastasis (bilateral humerus, right frontal 
region, costal arcs with pathological fracture of 
femur and radius) and the patient started 
chemotherapy (three courses of EPOCH 
chemotherapy). 
 
 
Fig. 3. The clinical follow-up of maxillary 
region with no signals of recurrence
 
 
Fig. 4. Serological exams and correlation with 
clinical oral manifestation of PBL
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-up during the 
 
 
 
 
3. DISCUSSION 
 
Plasmablastic Lymphoma affects, predominantly, 
males in their fourth decade of 
HIV-positive patients. PBL commonly affects 
extranodal sites, predominantly the oral cavity, 
gastrointestinal tract and the skin 
Contrasting, in the present case, our patient is a 
female patient and had a more advanced age 
than most seropositive patients. The best 
prognosis is associated with younger patients, 
early stage of the disease and no lymph node 
involved [12]. 
 
The literature proposes that a SR of tumors can 
be related to the efficiency of the immune 
system. This behavior may act by different ways: 
blocking cell growth or proliferation, inducing 
apoptosis and activating natural killer cells 
One hypothesis to explain SR of lymphomas is 
that the local trauma caused by the incisional 
biopsy triggers the local immune system t
healing response, and to resolve the tumor 
The radiation hypothesis suggests that doses 
received by the patient from imaginologic 
procedures can contribute to SR of PBL 
our case the patient was submitted to a single 
digital panoramic radiograph with an average 
dose of 100 mGy. Furthermore, the patient 
reported the use of phytotherapic ointment: olive 
oil and Malva sylvestris topically, several times. 
These substances act as anti
agents contributing with the lesion regression 
[16,17]. 
 
PBL resolution without any form of intervention 
such as surgery, radiotherapy, chemotherapy is 
rare. In the few cases reported of PBL SR 
(Table 1) it was not possible to pro
profile, even when considering multiple viral 
infections (EBV, HHV8 and HIV) to try predicting 
this phenomenon. 
 
HAART can present a dual behavior in 
seropositive patients regarding the manifestation 
of PBL. Reported cases describing 
high viral load and decompensated immune 
system with PBL; after HAART, they regularized 
CD4/CD8 rates and the spontaneous resolution 
of the neoplasia occurred. A possible explanation 
is immune function reconstitution and the viral 
load control [4,5]. On the other hand, the use of 
HAART might trigger the Immune Reconstitution 
Inflammatory Syndrome, [18] and this 
phenomenon results in the uncontrolled 
production of inflammatory cells leading to 
development of PBL [5,19]. In the present case, 
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life, usually in 
[3]. 
[13]. 
o the 
[14]. 
[15]. In 
-inflammatory 
 
pose a patient 
- patients with 
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the clinical lesion appearance and SR occurred 
after the HAART, when the viral load was 
undetectable and the patient immune system 
was already reestablished (Fig. 4). 
 
Differential diagnosis of ulcerated swelling at 
oropharyngeal mucosa in immunosuppressed 
patients (post-transplant or HIV positive) may 
consider lymphoproliferative disorders as EBV-
positive mucocutaneous ulcers. Histologically 
shows lymphocytes, immunoblasts plasma cells, 
histiocytes and eosinophils with atypical large B-
cell blasts, plasmacytoid apoptotic cells, with 
immunopositivity for  CD20+, CD79a+, PAX5+, 
Oct-2+ and Bob.1+ [20]. Complete remission of 
this disease when immunosuppressant were 
reduced or when immune system are recovered 
are reported in the literature [21].
 
The reported 
case is negative for EBV and for CD20 and the 
patient was immunocompetent since the 
appearance of the oral lesion, thus we discarded 
the EBV driven lesion diagnostic.  
 
Metastases can occur after the complete 
remission of primary tumor; in our case the 
patient presented metastasis of the oral PBL in 
bones with femur and radius fracture; other case 
report related oral metastasis in breast and bone 
marrow after 2 months [22]; for this reason the 
PBL patient’s follow-up is mandatory. The 
metastatic appearance may be identified by 
MMP value study as also by computerized 
tomography imaging (CTi) and colonoscopy in 
abdominal cases [23,24], in our case report, the 
metastasis was diagnosed by PET-scan exam.  
 
4. CONCLUSION 
 
Lymphomas are common in seropositive 
patients, but SR of these hematopoietic tumors, 
especially PBL, remains a dilemma. The 
mechanism involved includes factors that host 
co-infections and immune system recovery. A 
bigger number of cases may contribute to clarify 
possible associations. There are no defined 
protocols to manage these patients yet, even 
though there is a consensus which recommends 
a long term follow-up because of a recurrence 
risk and possibility of distant metastases. 
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